Insmed
INSM
193 hedge funds and large institutions have $3.35B invested in Insmed in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 75 increasing their positions, 63 reducing their positions, and 23 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 63
0.01% more ownership
Funds ownership: 107.05% → 107.06% (+0.01%)
2% less capital invested
Capital invested by funds: $3.42B → $3.35B (-$74.3M)
4% less funds holding
Funds holding: 202 → 193 (-9)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
28% less call options, than puts
Call options by funds: $2.88M | Put options by funds: $4.01M
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
Top Buyers
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$22.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$15.5M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$14.6M |
| 5 |
BlackRock
New York
|
+$14.4M |
Top Sellers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$27.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.9M |
| 4 |
Goldman Sachs
New York
|
-$13.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.74M |
INSM Hedge Fund Activity: Q3 2021 in Review
193 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2021, worth a combined $3.35B — down 2.2% from $3.42B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of INSM and 15 opened new positions — a net loss of 8 holders — while 63 trimmed existing stakes and 75 added.
The largest buyer was Polar Capital Holdings, adding an estimated $22.6M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $27.5M sold.
- 193 institutional investors held Insmed (INSM) as of Q3 2021, down from 202 in Q2 2021.
- Funds reported $3.35B of Insmed stock for Q3 2021, down 2.2% quarter-over-quarter.
- 15 funds opened new Insmed positions in Q3 2021 and 23 closed out, a net change of -8 holders.
- The largest Insmed buyer in Q3 2021 was Polar Capital Holdings, an estimated $22.6M added.
- The largest Insmed seller in Q3 2021 was Westfield Capital Management, an estimated $27.5M sold.
Based on aggregated 13F filings for Q3 2021.